| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/20/2006 | WO2006076706A1 Cinnamide and hydrocinnamide derivatives with raf-kinase inhibitory activity |
| 07/20/2006 | WO2006076630A1 N-((2z)-2-((4-hydroxyphenyl)imino)-1,2-dihydro-3-pyridinyl)-4-methoxybenzenesulfonamide crystalline form 2 |
| 07/20/2006 | WO2006076593A1 1,3-diaryl substituted ureas as modulators of kinase activity |
| 07/20/2006 | WO2006076592A1 1,3 substituted diaryl ureas as modulators of kinase activity |
| 07/20/2006 | WO2006076511A1 N-(2-((4-hydroxyphenyl)amino)pyridin-3-yl)-4-methoxybenzenesulfonamide crystalline form 1 |
| 07/20/2006 | WO2006076442A2 Triazolopyrimidine derivatives |
| 07/20/2006 | WO2006076387A2 Cyanidin-3-glucoside as an anti-neoplastic agent |
| 07/20/2006 | WO2006076202A1 Heterocyclic carboxamide compounds as steroid nuclear receptors ligands |
| 07/20/2006 | WO2006075924A1 Antineoplastic preparation and the use of antineoplastic preparation |
| 07/20/2006 | WO2006075819A1 Gene delivery system containing relaxin gene and pharmaceutical composition using relaxin |
| 07/20/2006 | WO2006075784A1 ANTI-α9 INTEGRIN ANTIBODY AND THE USE THEREOF |
| 07/20/2006 | WO2006075678A1 Photosensitive compound |
| 07/20/2006 | WO2006075668A1 STABILIZED HUMAN IgG1 AND IgG3 ANTIBODIES |
| 07/20/2006 | WO2006075165A1 Combination of oncolytic viruses with angiogenesis inhibitors |
| 07/20/2006 | WO2006075160A1 N-phenyl-4-pyridin-2-yl-benzamide derivatives as histone deacylase (hdac) inhibitors for the treatment of cancer |
| 07/20/2006 | WO2006075152A1 4- (1h-indol-3-yl) -pyrimidin-2-ylamine derivates and their use in therapy |
| 07/20/2006 | WO2006075095A2 Use of purine derivatives as hsp90 protein inhibitors and for treatment of cancer |
| 07/20/2006 | WO2006075094A2 Purine derivatives compositions containing the same and use thereof against cancer |
| 07/20/2006 | WO2006074985A1 5-membered annelated heterocyclic pyrimidines as kinase inhibitors |
| 07/20/2006 | WO2006074984A1 Pyrazolopyrimidines as cell cycle kinase inhibitors |
| 07/20/2006 | WO2006074914A2 Human rna helicase and therapeutic uses thereof |
| 07/20/2006 | WO2006074526A1 Method and composition for treatment of neoplasms |
| 07/20/2006 | WO2006060419A9 Biomarkers for pre-selection of patients for anti-igf1r therapy |
| 07/20/2006 | WO2006060318A3 Quinolines and quinazoline analogs and their use as medicaments for treating cancer |
| 07/20/2006 | WO2006045750A3 T-cell stimulatory peptides from the melanoma-associated chondroitin sulfate proteoglycan and their use |
| 07/20/2006 | WO2006044687A3 Kinase inhibitors |
| 07/20/2006 | WO2006037032A3 Prodrugs of protein tyrosine kinase inhibitors |
| 07/20/2006 | WO2006015060A3 Isoindoline compounds and methods of their use |
| 07/20/2006 | WO2005096693A3 Cancer prognosis and/or diagnosis method |
| 07/20/2006 | WO2005075021A3 Chemically-modified human growth hormone receptor antagonist conjugates |
| 07/20/2006 | US20060160997 Tumor-associated antigen specific immunoglobulin fusion for use in diagnosis, prevention and treatment of cell proliferative |
| 07/20/2006 | US20060160897 Topical Use of Valproic Acid for the Prevention or Treatment of Skin Disorders |
| 07/20/2006 | US20060160890 Triterpenoid derivatives |
| 07/20/2006 | US20060160889 4-benzyl-2-phenylchroman skeleton with hydroxyl substitutions compounds; estrogen beta -receptors (ER beta ) modulator; hormone replacement therapy; osteoporosis, postmenopause; side effect reduction |
| 07/20/2006 | US20060160882 Indoline derivatives |
| 07/20/2006 | US20060160858 Administering N-Cyclopropyl-2-{3-[(E)-2-(4-methyl-pyridin-2-yl)-vinyl]-1H-indazol-6-ylamino}-benzamide for treating ophthalmic disease which is age related macular degeneration, diabetic retinopathy, or neovascular glaucoma |
| 07/20/2006 | US20060160856 Diarylurea derivatives and their use as chloride channel blockers |
| 07/20/2006 | US20060160832 Nitrogen-containing aromatic derivatives |
| 07/20/2006 | US20060160829 Thienopyrimidine compounds and use thereof |
| 07/20/2006 | US20060160796 N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders; cancer, and other diseases |
| 07/20/2006 | US20060160782 2-Substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumour action |
| 07/20/2006 | US20060160779 2,2-Di-substituted 1alpha,25-dihydroxy-19-norvitamin d derivative |
| 07/20/2006 | US20060160778 recognize and bind the tubulin site: antitubulin; useful for treating pathological states which arise from or are exacerbated by cell proliferation as anticancer and/or antiangiogenic activity |
| 07/20/2006 | US20060160775 synergistic mixture of 4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazoline and N-acetylcolchinol-O-phosphate, for the treatment of cancers; angiogenesis inhibitors and vascular permeability reducing effect in mammals |
| 07/20/2006 | US20060160768 Novel polysaccharides with antithrombotic activity comprising at least one covalent bond with biotin or a biotin derivative |
| 07/20/2006 | US20060160765 Inhibitors of nucleoside phosphorylases and nucleosidases |
| 07/20/2006 | US20060160764 LIMKs as modifiers of p53 pathway and methods of use |
| 07/20/2006 | US20060160755 Neoadjuvant treatment of breast cancer |
| 07/20/2006 | US20060160745 Agents for preventing postoperative recurrence of premenopausal breast cancer |
| 07/20/2006 | US20060160723 Glycoproteins having lipid mobilising properties and therapeutic applications thereof |
| 07/20/2006 | US20060160159 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 07/20/2006 | US20060160154 Materials and methods for detection and treatment of breast cancer |
| 07/20/2006 | US20060160145 Assay that makes use of the interaction of early pregnancy factor (EPF) or an EPF-related peptide with a human dorsal root receptor (hDRR) or hDRR related receptor; also useful to determine whether the test compound is an agonist or antagonist of hDRRs |
| 07/20/2006 | US20060160132 Diagnositics and therapeutics for diseases associated with g-protein coupled receptor hm74a (hm74a) |
| 07/20/2006 | US20060160083 Diagnositics and therapeutics for diseases associated with human g-protein couple receptor 14 (gpr14) |
| 07/20/2006 | US20060159739 Liposomes containing an entrapped compound in supersaturated solution |
| 07/20/2006 | US20060159692 Transcriptional factor inducing apoptosis in cancer cell |
| 07/20/2006 | US20060159687 Modified aerolysin and methods of use for treating lung cancer |
| 07/20/2006 | US20060159683 Stabilization of chimeric immunoglobulin; obtain immunoglobulin, monitor structure, determine sequence, adjust amino acid sequences for greater stability |
| 07/20/2006 | US20060159662 Therapeutic anti-melanoma compounds |
| 07/20/2006 | US20060159657 Formulations of lymphokines and method of use thereof for local or both local and systemic control of proliferative cell disorders |
| 07/20/2006 | US20060159638 O/W emulsions comprising micronized biologically active agents |
| 07/20/2006 | US20060159626 Method for administering a cytokine to the central nervous system and the lymphatic system |
| 07/20/2006 | CA2595075A1 Pyrrolodihydroisoquinolines as antiproliferative agents |
| 07/20/2006 | CA2594860A1 Cinnamide and hydrocinnamide derivatives with raf-kinase inhibitory activity |
| 07/20/2006 | CA2594654A1 N-((2z)-2-((4-hydroxyphenyl)imino)-1,2-dihydro-3-pyridinyl)-4-methoxybenzenesulfonamide crystalline form 2 |
| 07/20/2006 | CA2594449A1 1,3-diaryl substituted ureas as modulators of kinase activity |
| 07/20/2006 | CA2594425A1 5-membered annelated heterocyclic pyrimidines as kinase inhibitors |
| 07/20/2006 | CA2594422A1 Pyrazolopyrimidines as cell cycle kinase inhibitors |
| 07/20/2006 | CA2593780A1 The use of alpha-ketoglutarate in the treatment or prophylaxis of neoplastic disease |
| 07/20/2006 | CA2593777A1 Anti-.alpha.9 integrin antibody and the use thereof |
| 07/20/2006 | CA2593697A1 Pan-her antagonists and methods of use |
| 07/20/2006 | CA2593684A1 Cancer-targeted viral vectors |
| 07/20/2006 | CA2593582A1 Bendamustine pharmaceutical compositions |
| 07/20/2006 | CA2593541A1 Identification of phospholipase a2 as target in cancer treatment, with special emphasis on colorectal cancer and its mechanism of action |
| 07/20/2006 | CA2593156A1 Heterocyclic carboxamide compounds as steroid nuclear receptors ligands |
| 07/20/2006 | CA2592723A1 4- (1h-indol-3-yl) -pyrimidin-2-ylamine derivates and their use in therapy |
| 07/19/2006 | EP1681348A1 MU-1 member of the cytokine receptor family |
| 07/19/2006 | EP1681305A2 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 07/19/2006 | EP1681290A2 Imidazole derivatives, production method thereof and use thereof |
| 07/19/2006 | EP1681062A1 Antibacterial drug for propionibacterium acnes |
| 07/19/2006 | EP1680963A1 Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses |
| 07/19/2006 | EP1680472A2 Compounds for dual photodiagnosis and therapy |
| 07/19/2006 | EP1680449A1 Non-human transgenic mammal for the constant region of the class a human immunoglobulin heavy chain and applications therof |
| 07/19/2006 | EP1680425A1 6- [(substituted)phenyl] triazolopyrimidines as anticancer agents |
| 07/19/2006 | EP1680420A2 Compounds, compositions, and methods |
| 07/19/2006 | EP1680417A1 1-'(e)-2-(phenyl)ethenyl-4-(arylalkoxy)-oxazole or -thiazole compounds as her-2 tyrosine kinases inhibitors and their use in the treatment of cancer |
| 07/19/2006 | EP1680415A1 Pyrrolidinyl urea derivatives as angiogenesis inhibitors |
| 07/19/2006 | EP1680413A1 New rar$g(b) receptor-activating ligand, method for the preparation thereof and use thereof in human medicine and in cosmetics |
| 07/19/2006 | EP1680138A1 Combination therapy |
| 07/19/2006 | EP1680136A1 Peptides having, for example, an antiangiogenic activity and applications thereof in therapeutics |
| 07/19/2006 | EP1680123A1 Use |
| 07/19/2006 | EP1680108A1 Pyridothiophene compounds |
| 07/19/2006 | EP1680103A1 Acid containing oxaliplatin formulations |
| 07/19/2006 | EP1483284B1 Selective dipeptide inhibitors of kallikrein |
| 07/19/2006 | EP1476166B1 Use of low molecular weight compounds for preparing a medicament useful in treating mutant p53 mediated diseases |
| 07/19/2006 | EP1442058B1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 07/19/2006 | EP1379695B1 New polynucleotides and polypeptides of the ifnalpha-21 gene |
| 07/19/2006 | EP1370556B1 Metalloproteinase inhibitors |
| 07/19/2006 | EP1301507B1 Mannich base prodrugs of 3 - (pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases |